With both seasonal influenza and H1N1 influenza circulating this flu season, the American Medical Association (AMA) today announces it has expedited the publication of a new code specific to vaccine administration and revised existing code 90663 to include the H1N1 vaccine.
The new Current Procedural Terminology (CPT) code issued by the AMA will streamline the reporting and reimbursement procedure for physicians and healthcare providers who are expected to administer nearly 200 million doses of the H1N1 vaccine in the United States. The codes will also help to efficiently report and track immunization and counseling services related to the H1N1 vaccine throughout the health care system.
In consultation with the U.S. Department of Health and Human Services, the AMA CPT Editorial Panel created code 90470 to report H1N1 immunization administration and counseling. Code 90663 was revised by the CPT Editorial Panel to refer specifically to the H1N1 vaccine product. Both, revised code 90663 and Category I CPT Code 90470 are effective immediately.
For quick reference, the two codes are:
90470—H1N1 immunization administration (intramuscular, intranasal), including counseling when performed
90663—Influenza virus vaccine, pandemic formulation, H1N1
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.